Asthma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1065110
  • May 2021
  • Pharmaceuticals
  • 127 Pages
The global Asthma Therapeutics market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Asthma Therapeutics market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Asthma Therapeutics market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Asthma Therapeutics market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Philips Healthcare, AstraZeneca Plc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Merck & Co., Inc., Roche Diagnostics
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Asthma Therapeutics market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Asthma Therapeutics market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Asthma Therapeutics market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Asthma Therapeutics market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Asthma Therapeutics Market:
The Asthma Therapeutics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Philips Healthcare, AstraZeneca Plc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc., Merck & Co., Inc., Roche Diagnostics

Asthma Therapeutics Market Segment Analysis:
by Product Type
Dry powder inhalers
Metered dose inhalers
Mist inhalers
Nebulizer
Drug Class
Anti-inflammatory drugs
Bronchodilators
Combination therapy
Route of administration
Oral
Inhaled
Intravenous
Subcutaneous

Geographic Coverage for Asthma Therapeutics Market:
The market research report on global Asthma Therapeutics market offers complete analysis across various regions across the world. The Asthma Therapeutics market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Asthma Therapeutics market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Asthma Therapeutics Market Value and Forecast
  • US
  • Canada
Europe Asthma Therapeutics Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Asthma Therapeutics Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Asthma Therapeutics Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Asthma Therapeutics Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Asthma Therapeutics market report:
  • The report provides key trends of the global Asthma Therapeutics market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Asthma Therapeutics industry
  • The report covers all the recent developments of the Asthma Therapeutics market and helps to provide current industry updates
  • The report covers a detailed look over the global Asthma Therapeutics Industry and provides with significant actionable insights
  • The Asthma Therapeutics market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Asthma Therapeutics market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Asthma Therapeutics market
  • Comprehensive analysis of the Asthma Therapeutics market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Asthma Therapeutics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Asthma Therapeutics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Asthma Therapeutics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Asthma Therapeutics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Asthma Therapeutics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Philips Healthcare
  • AstraZeneca Plc.
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim GmbH
  • Sanofi-Aventis SA
  • CareFusion Corporation
  • Sunovion Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Roche Diagnostics
  • Dry powder inhalers
  • Metered dose inhalers
  • Mist inhalers
  • Nebulizer
  • Oral
  • Inhaled
  • Intravenous
  • Subcutaneous

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Asthma Therapeutics Market Snapshot
          2.1.1. Global Asthma Therapeutics Market By Product Type,2019
               2.1.1.1.Dry powder inhalers
               2.1.1.2.Metered dose inhalers
               2.1.1.3.Mist inhalers
               2.1.1.4.Nebulizer
          2.1.2. Global Asthma Therapeutics Market By Route of administration,2019
               2.1.2.1.Oral
               2.1.2.2.Inhaled
               2.1.2.3.Intravenous
               2.1.2.4.Subcutaneous
          2.1.3. Global Asthma Therapeutics Market By End-use,2019
          2.1.4. Global Asthma Therapeutics Market By Geography,2019

3. Global Asthma Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Product Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Product Type, 2020
     4.2. Global Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028

5. Global Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Route of administration, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Route of administration, 2020
     5.2. Global Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028

6. Global Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Asthma Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Asthma Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Asthma Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028
          7.2.3. North America Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028
          7.2.4. North America Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Asthma Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Asthma Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028
          7.3.3. Europe Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028
          7.3.4. Europe Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Asthma Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Asthma Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028
          7.4.3. Asia Pacific Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028
          7.4.4. Asia Pacific Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Asthma Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Asthma Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028
          7.5.3. Latin America Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028
          7.5.4. Latin America Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Asthma Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Asthma Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Asthma Therapeutics Market Size (US$), By Product Type, 2018 – 2028
          7.6.3. MEA Asthma Therapeutics Market Size (US$), By Route of administration, 2018 – 2028
          7.6.4. MEA Asthma Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Asthma Therapeutics Providers
        8.4.1 Philips Healthcare
                8.4.1.1 Business Description
                8.4.1.2 Philips Healthcare Geographic Operations
                8.4.1.3 Philips Healthcare Financial Information
                8.4.1.4 Philips Healthcare Product Positions/Portfolio
                8.4.1.5 Philips Healthcare Key Developments
        8.4.2 AstraZeneca Plc.
                8.4.2.1 Business Description
                8.4.2.2 AstraZeneca Plc. Geographic Operations
                8.4.2.3 AstraZeneca Plc. Financial Information
                8.4.2.4 AstraZeneca Plc. Product Positions/Portfolio
                8.4.2.5 AstraZeneca Plc. Key Developments
        8.4.3 GlaxoSmithKline Plc.
                8.4.3.1 Business Description
                8.4.3.2 GlaxoSmithKline Plc. Geographic Operations
                8.4.3.3 GlaxoSmithKline Plc. Financial Information
                8.4.3.4 GlaxoSmithKline Plc. Product Positions/Portfolio
                8.4.3.5 GlaxoSmithKline Plc. Key Developments
        8.4.4 Teva Pharmaceutical Industries Ltd.
                8.4.4.1 Business Description
                8.4.4.2 Teva Pharmaceutical Industries Ltd. Geographic Operations
                8.4.4.3 Teva Pharmaceutical Industries Ltd. Financial Information
                8.4.4.4 Teva Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.4.5 Teva Pharmaceutical Industries Ltd. Key Developments
        8.4.5 Boehringer Ingelheim GmbH
                8.4.5.1 Business Description
                8.4.5.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.5.3 Boehringer Ingelheim GmbH Financial Information
                8.4.5.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.5.5 Boehringer Ingelheim GmbH Key Developments
        8.4.6 Sanofi-Aventis SA
                8.4.6.1 Business Description
                8.4.6.2 Sanofi-Aventis SA Geographic Operations
                8.4.6.3 Sanofi-Aventis SA Financial Information
                8.4.6.4 Sanofi-Aventis SA Product Positions/Portfolio
                8.4.6.5 Sanofi-Aventis SA Key Developments
        8.4.7 CareFusion Corporation
                8.4.7.1 Business Description
                8.4.7.2 CareFusion Corporation Geographic Operations
                8.4.7.3 CareFusion Corporation Financial Information
                8.4.7.4 CareFusion Corporation Product Positions/Portfolio
                8.4.7.5 CareFusion Corporation Key Developments
        8.4.8 Sunovion Pharmaceuticals, Inc.
                8.4.8.1 Business Description
                8.4.8.2 Sunovion Pharmaceuticals, Inc. Geographic Operations
                8.4.8.3 Sunovion Pharmaceuticals, Inc. Financial Information
                8.4.8.4 Sunovion Pharmaceuticals, Inc. Product Positions/Portfolio
                8.4.8.5 Sunovion Pharmaceuticals, Inc. Key Developments
        8.4.9 Merck & Co., Inc.
                8.4.9.1 Business Description
                8.4.9.2 Merck & Co., Inc. Geographic Operations
                8.4.9.3 Merck & Co., Inc. Financial Information
                8.4.9.4 Merck & Co., Inc. Product Positions/Portfolio
                8.4.9.5 Merck & Co., Inc. Key Developments
        8.4.10 Roche Diagnostics
                8.4.10.1 Business Description
                8.4.10.2 Roche Diagnostics Geographic Operations
                8.4.10.3 Roche Diagnostics Financial Information
                8.4.10.4 Roche Diagnostics Product Positions/Portfolio
                8.4.10.5 Roche Diagnostics Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Asthma Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Asthma Therapeutics Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Asthma Therapeutics Market Revenue, By Route of administration, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Asthma Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Asthma Therapeutics Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Asthma Therapeutics Market Revenue, By Route of administration, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Asthma Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Asthma Therapeutics Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Asthma Therapeutics Market Revenue, By Route of administration, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Asthma Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Asthma Therapeutics Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Asthma Therapeutics Market Revenue, By Route of administration, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Asthma Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Asthma Therapeutics Market Revenue, By Product Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Asthma Therapeutics Market Revenue, By Route of administration, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Asthma Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Asthma Therapeutics: Market Segmentation 
FIG. 2 Global Asthma Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Asthma Therapeutics Market, By Product Type, 2019 (US$ Mn) 
FIG. 5 Global Asthma Therapeutics Market, By Route of administration, 2019 (US$ Mn) 
FIG. 6 Global Asthma Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Asthma Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Asthma Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Asthma Therapeutics Providers, 2019
FIG. 11 Global Asthma Therapeutics Market Revenue Contribution, By Product Type, 2019 & 2028 (Value %) 
FIG. 12 Global Asthma Therapeutics Market Revenue Contribution, By Route of administration, 2019 & 2028 (Value %) 
FIG. 13 Global Asthma Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Asthma Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Asthma Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Asthma Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Asthma Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Asthma Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Asthma Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Asthma Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Asthma Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Asthma Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Asthma Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Asthma Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Asthma Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Asthma Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Asthma Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Asthma Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Asthma Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Asthma Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Asthma Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Asthma Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Asthma Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Asthma Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Asthma Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Philips Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AstraZeneca Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi-Aventis SA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CareFusion Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sunovion Pharmaceuticals, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck & Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Roche Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Asthma Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Asthma Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Asthma Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Asthma Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Asthma Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Asthma Therapeutics Providers, 2016
FIG.  Global Asthma Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Metered dose inhalers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Mist inhalers Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Nebulizer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Asthma Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Inhaled Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Intravenous Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Subcutaneous Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Asthma Therapeutics Market Value, 2018 – 2028, (US$ Mn)